Al Hammadi Company for Development and Investment reported a net profit after Zakat and tax of SAR 64.1 million for H1 2020, a 45% increase compared to SAR 44.2 million a year earlier.
Item | 6m 2019 | 6m 2020 | Change |
---|---|---|---|
Revenues | 483.51 | 450.99 | (6.7 %) |
Gross Income | 136.69 | 157.29 | 15.1 % |
Operating Income | 58.14 | 86.99 | 49.6 % |
Net Income | 44.18 | 64.05 | 45.0 % |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.28 | 0.40 | 45.0 % |
The higher net profit was backed by improved performance of Hospital Al-Nuzha branch, higher inpatient revenues, due to the increased referrals from the Ministry of Health, and a decline in some expenses and staff costs.
Moreover, a decrease in finance costs due to lower loan balances and lower lending cost also boosted the first-half figures.
Item | Q2 2019 | Q2 2020 | Change |
---|---|---|---|
Revenues | 253.83 | 244.30 | (3.8 %) |
Gross Income | 71.08 | 90.81 | 27.7 % |
Operating Income | 30.95 | 53.15 | 71.8 % |
Net Income | 20.01 | 39.10 | 95.4 % |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.13 | 0.24 | 95.4 % |
Item | Q1 2020 | Q2 2020 | Change |
---|---|---|---|
Revenues | 206.69 | 244.30 | 18.2 % |
Gross Income | 66.48 | 90.81 | 36.6 % |
Operating Income | 33.84 | 53.15 | 57.0 % |
Net Income | 24.94 | 39.10 | 56.8 % |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.16 | 0.24 | 56.8 % |
The second-quarter net profit surged 95% year-on-year to SAR 39.1 million, driven by improved performance of Hospital Al-Nuzha branch, higher inpatient revenues, and a decrease in finance costs.
When compared to the previous quarter, net profit climbed 57% on higher inpatient revenues and a decline in some expenses and staff costs.
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2011 | - | - | - | - | - | - |
Q2 2011 | - | - | - | - | - | - |
Q3 2011 | - | - | - | - | - | - |
Q4 2011 | - | - | - | - | - | - |
2011 | 330.66 | 9.7 % | 147.65 | 8.3 % | 92.15 | 4.9 % |
Q1 2012 | - | - | - | - | - | - |
Q2 2012 | - | - | - | - | - | - |
Q3 2012 | - | - | - | - | - | - |
Q4 2012 | - | - | - | - | - | - |
2012 | 378.68 | 14.5 % | 163.11 | 10.5 % | 92.34 | 0.2 % |
Q1 2013 | 104.84 | - | 47.34 | - | 30.09 | - |
Q2 2013 | 108.85 | - | 45.84 | - | 22.74 | - |
Q3 2013 | 96.26 | - | 36.81 | - | 19.02 | - |
Q4 2013 | 124.13 | - | 55.17 | - | 34.34 | - |
2013 | 434.08 | 14.6 % | 185.16 | 13.5 % | 112.10 | 21.4 % |
Q1 2014 | 122.04 | 16.4 % | 54.71 | 15.6 % | 35.96 | 19.5 % |
Q2 2014 | 121.66 | 11.8 % | 53.68 | 17.1 % | 35.77 | 57.3 % |
Q3 2014 | 108.83 | 13.1 % | 44.74 | 21.5 % | 24.77 | 30.3 % |
Q4 2014 | 129.43 | 4.3 % | 55.99 | 1.5 % | 34.52 | 0.5 % |
2014 | 481.96 | 11.0 % | 209.11 | 12.9 % | 130.95 | 16.8 % |
Q1 2015 | 129.48 | 6.1 % | 50.64 | (7.4 %) | 33.35 | (7.3 %) |
Q2 2015 | 137.36 | 12.9 % | 63.56 | 18.4 % | 37.91 | 6.0 % |
Q3 2015 | 136.80 | 25.7 % | 57.97 | 29.6 % | 31.92 | 28.8 % |
Q4 2015 | 157.70 | 21.8 % | 68.06 | 21.6 % | 40.39 | 17.0 % |
2015 | 561.33 | 16.5 % | 240.24 | 14.9 % | 143.57 | 9.6 % |
Q1 2016 | 144.16 | 11.3 % | 54.75 | 8.1 % | 26.66 | (20.0 %) |
Q2 2016 | 138.08 | 0.5 % | 57.56 | (9.5 %) | 27.63 | (27.1 %) |
Q3 2016 | 141.35 | 3.3 % | 56.48 | (2.6 %) | 25.97 | (18.6 %) |
Q4 2016 | 182.65 | 15.8 % | 73.35 | 7.8 % | 18.58 | (54.0 %) |
2016 | 606.24 | 8.0 % | 242.13 | 0.8 % | 98.81 | (31.2 %) |
Q1 2017 | 180.23 | 25.0 % | 62.02 | 13.3 % | 33.61 | 26.0 % |
Q2 2017 | 176.71 | 28.0 % | 58.16 | 1.0 % | 32.88 | 19.0 % |
Q3 2017 | 163.01 | 15.3 % | 53.91 | (4.5 %) | 26.46 | 1.9 % |
Q4 2017 | 188.69 | 3.3 % | 65.08 | (11.3 %) | 33.93 | 82.6 % |
2017 | 708.62 | 16.9 % | 239.16 | (1.2 %) | 126.88 | 28.4 % |
Q1 2018 | 200.67 | 11.3 % | 66.84 | 7.8 % | 38.29 | 13.9 % |
Q2 2018 | 214.49 | 21.4 % | 53.28 | (8.4 %) | 28.26 | (14.0 %) |
Q3 2018 | 250.40 | 53.6 % | 64.92 | 20.4 % | 31.19 | 17.9 % |
Q4 2018 | 228.04 | 20.9 % | 65.32 | 0.4 % | 29.53 | (13.0 %) |
2018 | 893.60 | 26.1 % | 250.36 | 4.7 % | 127.27 | 0.3 % |
Q1 2019 | 229.68 | 14.5 % | 65.60 | (1.9 %) | 27.20 | (29.0 %) |
Q2 2019 | 253.83 | 18.3 % | 71.08 | 33.4 % | 30.95 | 9.5 % |
Q3 2019 | 220.00 | (12.1 %) | 62.22 | (4.2 %) | 31.85 | 2.1 % |
Q4 2019 | 270.55 | 18.6 % | 83.72 | 28.2 % | 39.60 | 34.1 % |
2019 | 974.06 | 9.0 % | 282.62 | 12.9 % | 129.59 | 1.8 % |
Q1 2020 | 206.69 | (10.0 %) | 66.48 | 1.3 % | 33.84 | 24.4 % |
Q2 2020 | 244.30 | (3.8 %) | 90.81 | 27.7 % | 53.15 | 71.8 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2010 | 301.55 | (2.7 %) | 136.40 | 8.4 % | 87.88 | 8.6 % |
2011 | 330.66 | 9.7 % | 147.65 | 8.3 % | 92.15 | 4.9 % |
2012 | 378.68 | 14.5 % | 163.11 | 10.5 % | 92.34 | 0.2 % |
2013 | 434.08 | 14.6 % | 185.16 | 13.5 % | 112.10 | 21.4 % |
2014 | 481.96 | 11.0 % | 209.11 | 12.9 % | 130.95 | 16.8 % |
2015 | 561.33 | 16.5 % | 240.24 | 14.9 % | 143.57 | 9.6 % |
2016 | 606.24 | 8.0 % | 242.13 | 0.8 % | 98.81 | (31.2 %) |
2017 | 708.62 | 16.9 % | 239.16 | (1.2 %) | 126.88 | 28.4 % |
2018 | 893.60 | 26.1 % | 250.36 | 4.7 % | 127.27 | 0.3 % |
2019 | 974.06 | 9.0 % | 282.62 | 12.9 % | 129.59 | 1.8 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2011 | - | - | - | - | - | - |
Q2 2011 | - | - | - | - | - | - |
Q3 2011 | - | - | - | - | - | - |
Q4 2011 | - | - | - | - | - | - |
2011 | 89.94 | 12.6 % | 0.56 | - | 89.94 | 0.56 |
Q1 2012 | - | - | - | - | - | - |
Q2 2012 | - | - | - | - | - | - |
Q3 2012 | - | - | - | - | - | - |
Q4 2012 | - | - | - | - | - | - |
2012 | 94.27 | 4.8 % | 0.59 | - | 94.27 | 0.59 |
Q1 2013 | 29.83 | - | 0.19 | - | 29.83 | 0.19 |
Q2 2013 | 30.06 | - | 0.19 | - | 24.06 | 0.15 |
Q3 2013 | 18.32 | - | 0.11 | - | 18.32 | 0.11 |
Q4 2013 | 33.29 | - | 0.21 | - | 33.29 | 0.21 |
2013 | 111.50 | 18.3 % | 0.70 | - | 111.50 | 0.70 |
Q1 2014 | 34.23 | 14.7 % | 0.21 | - | 34.23 | 0.21 |
Q2 2014 | 35.60 | 18.4 % | 0.22 | - | 35.60 | 0.22 |
Q3 2014 | 25.42 | 38.7 % | 0.16 | - | 25.42 | 0.16 |
Q4 2014 | 33.71 | 1.2 % | 0.21 | - | 33.71 | 0.21 |
2014 | 128.95 | 15.6 % | 0.81 | - | 128.95 | 0.81 |
Q1 2015 | 41.01 | 19.8 % | 0.26 | 9.80 | 31.21 | 0.20 |
Q2 2015 | 36.89 | 3.6 % | 0.23 | - | 36.89 | 0.23 |
Q3 2015 | 27.69 | 8.9 % | 0.17 | - | 27.69 | 0.17 |
Q4 2015 | 35.75 | 6.0 % | 0.22 | - | 35.75 | 0.22 |
2015 | 141.33 | 9.6 % | 0.88 | 9.80 | 131.53 | 0.82 |
Q1 2016 | 21.14 | (48.5 %) | 0.13 | - | 21.14 | 0.13 |
Q2 2016 | 20.63 | (44.1 %) | 0.13 | - | 20.63 | 0.13 |
Q3 2016 | 20.73 | (25.1 %) | 0.13 | - | 20.73 | 0.13 |
Q4 2016 | 10.48 | (70.7 %) | 0.07 | - | 10.48 | 0.07 |
2016 | 72.96 | (48.4 %) | 0.46 | - | 72.96 | 0.46 |
Q1 2017 | 27.97 | 32.3 % | 0.17 | - | 27.97 | 0.17 |
Q2 2017 | 25.66 | 24.4 % | 0.16 | - | 25.66 | 0.16 |
Q3 2017 | 23.59 | 13.8 % | 0.15 | - | 23.59 | 0.15 |
Q4 2017 | 30.76 | 193.4 % | 0.19 | - | 30.76 | 0.19 |
2017 | 107.97 | 48.0 % | 0.67 | - | 107.97 | 0.67 |
Q1 2018 | 30.88 | 10.4 % | 0.19 | - | 30.88 | 0.19 |
Q2 2018 | 19.93 | (22.3 %) | 0.12 | - | 19.93 | 0.12 |
Q3 2018 | 21.31 | (9.7 %) | 0.13 | - | 21.31 | 0.13 |
Q4 2018 | 17.70 | (42.5 %) | 0.11 | - | 17.70 | 0.11 |
2018 | 89.81 | (16.8 %) | 0.56 | - | 89.81 | 0.56 |
Q1 2019 | 24.17 | (21.7 %) | 0.15 | - | 24.17 | 0.15 |
Q2 2019 | 20.01 | 0.4 % | 0.13 | - | 20.01 | 0.13 |
Q3 2019 | 21.17 | (0.6 %) | 0.13 | - | 21.17 | 0.13 |
Q4 2019 | 27.65 | 56.2 % | 0.17 | - | 27.65 | 0.17 |
2019 | 93.00 | 3.5 % | 0.58 | - | 93.00 | 0.58 |
Q1 2020 | 24.94 | 3.2 % | 0.16 | - | 24.94 | 0.16 |
Q2 2020 | 39.10 | 95.4 % | 0.24 | (4.99) | 44.10 | 0.28 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2010 | 79.87 | 4.5 % | 0.50 | - | 79.87 | 0.50 |
2011 | 89.94 | 12.6 % | 0.56 | - | 89.94 | 0.56 |
2012 | 94.27 | 4.8 % | 0.59 | - | 94.27 | 0.59 |
2013 | 111.50 | 18.3 % | 0.70 | - | 111.50 | 0.70 |
2014 | 128.95 | 15.6 % | 0.81 | - | 128.95 | 0.81 |
2015 | 141.33 | 9.6 % | 0.88 | 9.80 | 131.53 | 0.82 |
2016 | 72.96 | (48.4 %) | 0.46 | - | 72.96 | 0.46 |
2017 | 107.97 | 48.0 % | 0.67 | - | 107.97 | 0.67 |
2018 | 89.81 | (16.8 %) | 0.56 | - | 89.81 | 0.56 |
2019 | 93.00 | 3.5 % | 0.58 | - | 93.00 | 0.58 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
2011 | 44.65 % | 31.79 % | 27.20 % |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
2012 | 43.07 % | 27.97 % | 24.89 % |
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | 42.66 % | 27.60 % | 24.31 % |
2013 | 42.66 % | 28.96 % | 25.69 % |
Q1 2014 | 42.66 % | 27.85 % | 24.35 % |
Q2 2014 | 43.18 % | 29.90 % | 26.17 % |
Q3 2014 | 43.70 % | 30.34 % | 26.97 % |
Q4 2014 | 43.39 % | 30.09 % | 26.75 % |
2014 | 43.39 % | 30.07 % | 26.75 % |
Q1 2015 | 41.90 % | 29.13 % | 25.73 % |
Q2 2015 | 42.55 % | 28.68 % | 25.19 % |
Q3 2015 | 42.80 % | 29.71 % | 24.29 % |
Q4 2015 | 42.80 % | 31.06 % | 23.43 % |
2015 | 42.80 % | 31.06 % | 23.43 % |
Q1 2016 | 42.42 % | 30.79 % | 21.09 % |
Q2 2016 | 41.32 % | 30.64 % | 18.24 % |
Q3 2016 | 40.74 % | 29.96 % | 16.90 % |
Q4 2016 | 39.94 % | 25.11 % | 12.04 % |
2016 | 39.94 % | 25.10 % | 12.03 % |
Q1 2017 | 38.83 % | 24.74 % | 12.43 % |
Q2 2017 | 36.71 % | 24.09 % | 12.46 % |
Q3 2017 | 35.22 % | 23.41 % | 12.48 % |
Q4 2017 | 33.75 % | 25.39 % | 15.24 % |
2017 | 33.75 % | 25.39 % | 15.24 % |
Q1 2018 | 33.46 % | 26.03 % | 15.21 % |
Q2 2018 | 31.18 % | 25.45 % | 13.71 % |
Q3 2018 | 29.28 % | 24.60 % | 12.04 % |
Q4 2018 | 28.02 % | 24.14 % | 10.05 % |
2018 | 28.02 % | 24.14 % | 10.05 % |
Q1 2019 | 27.00 % | 22.96 % | 9.01 % |
Q2 2019 | 27.75 % | 22.56 % | 8.65 % |
Q3 2019 | 28.36 % | 23.59 % | 8.92 % |
Q4 2019 | 29.01 % | 23.82 % | 9.55 % |
2019 | 29.01 % | 23.82 % | 9.55 % |
Q1 2020 | 29.81 % | 25.12 % | 9.86 % |
Q2 2020 | 32.21 % | 27.70 % | 12.52 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2010 | 45.23 % | 33.73 % | 26.49 % |
2011 | 44.65 % | 31.79 % | 27.20 % |
2012 | 43.07 % | 27.97 % | 24.89 % |
2013 | 42.66 % | 28.96 % | 25.69 % |
2014 | 43.39 % | 30.07 % | 26.75 % |
2015 | 42.80 % | 31.06 % | 23.43 % |
2016 | 39.94 % | 25.10 % | 12.03 % |
2017 | 33.75 % | 25.39 % | 15.24 % |
2018 | 28.02 % | 24.14 % | 10.05 % |
2019 | 29.01 % | 23.82 % | 9.55 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | 45.15 % | 31.89 % | 28.45 % |
Q2 2013 | 42.11 % | 24.00 % | 22.10 % |
Q3 2013 | 38.24 % | 23.34 % | 19.03 % |
Q4 2013 | 44.45 % | 30.42 % | 26.82 % |
Q1 2014 | 44.83 % | 32.21 % | 28.04 % |
Q2 2014 | 44.12 % | 32.25 % | 29.26 % |
Q3 2014 | 41.11 % | 26.05 % | 23.36 % |
Q4 2014 | 43.26 % | 29.45 % | 26.04 % |
Q1 2015 | 39.11 % | 28.49 % | 24.10 % |
Q2 2015 | 46.28 % | 30.21 % | 26.86 % |
Q3 2015 | 42.37 % | 30.62 % | 20.24 % |
Q4 2015 | 43.16 % | 34.31 % | 22.67 % |
Q1 2016 | 37.98 % | 27.65 % | 14.66 % |
Q2 2016 | 41.68 % | 29.60 % | 14.94 % |
Q3 2016 | 39.95 % | 27.83 % | 14.67 % |
Q4 2016 | 40.16 % | 17.59 % | 5.74 % |
Q1 2017 | 34.41 % | 25.82 % | 15.52 % |
Q2 2017 | 32.91 % | 26.06 % | 14.52 % |
Q3 2017 | 33.07 % | 24.41 % | 14.47 % |
Q4 2017 | 34.49 % | 25.21 % | 16.30 % |
Q1 2018 | 33.31 % | 28.10 % | 15.39 % |
Q2 2018 | 24.84 % | 23.98 % | 9.29 % |
Q3 2018 | 25.93 % | 21.86 % | 8.51 % |
Q4 2018 | 28.65 % | 23.30 % | 7.76 % |
Q1 2019 | 28.56 % | 22.87 % | 10.52 % |
Q2 2019 | 28.00 % | 22.30 % | 7.88 % |
Q3 2019 | 28.28 % | 26.14 % | 9.62 % |
Q4 2019 | 30.94 % | 24.16 % | 10.22 % |
Q1 2020 | 32.17 % | 28.77 % | 12.07 % |
Q2 2020 | 37.17 % | 32.12 % | 18.05 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2011 | - | - | - | - |
Q2 2011 | - | - | - | - |
Q3 2011 | - | - | - | - |
Q4 2011 | - | - | - | - |
Q1 2012 | - | - | - | - |
Q2 2012 | - | - | - | - |
Q3 2012 | - | - | - | - |
Q4 2012 | - | - | - | - |
Q1 2013 | 160.00 | - | - | 3.74 |
Q2 2013 | 160.00 | - | - | 3.67 |
Q3 2013 | 160.00 | - | - | 3.78 |
Q4 2013 | 160.00 | 0.70 | 0.66 | 3.66 |
Q1 2014 | 160.00 | 0.72 | 0.69 | 3.87 |
Q2 2014 | 160.00 | 0.76 | 0.76 | 7.88 |
Q3 2014 | 160.00 | 0.80 | 0.80 | 8.04 |
Q4 2014 | 160.00 | 0.81 | 0.81 | 8.25 |
Q1 2015 | 160.00 | 0.85 | 0.79 | 8.51 |
Q2 2015 | 160.00 | 0.86 | 0.80 | 8.27 |
Q3 2015 | 160.00 | 0.87 | 0.81 | 8.44 |
Q4 2015 | 160.00 | 0.88 | 0.82 | 8.66 |
Q1 2016 | 160.00 | 0.76 | 0.76 | 8.80 |
Q2 2016 | 160.00 | 0.66 | 0.66 | 8.37 |
Q3 2016 | 160.00 | 0.61 | 0.61 | 8.50 |
Q4 2016 | 160.00 | 0.46 | 0.46 | 8.56 |
Q1 2017 | 160.00 | 0.50 | 0.50 | 8.75 |
Q2 2017 | 160.00 | 0.53 | 0.53 | 8.89 |
Q3 2017 | 160.00 | 0.55 | 0.55 | 9.04 |
Q4 2017 | 160.00 | 0.67 | 0.67 | 8.67 |
Q1 2018 | 160.00 | 0.69 | 0.69 | 8.85 |
Q2 2018 | 160.00 | 0.66 | 0.66 | 8.98 |
Q3 2018 | 160.00 | 0.64 | 0.64 | 9.11 |
Q4 2018 | 160.00 | 0.56 | 0.56 | 9.24 |
Q1 2019 | 160.00 | 0.52 | 0.52 | 9.40 |
Q2 2019 | 160.00 | 0.52 | 0.52 | 9.51 |
Q3 2019 | 160.00 | 0.52 | 0.52 | 9.63 |
Q4 2019 | 160.00 | 0.58 | 0.58 | 9.79 |
Q1 2020 | 160.00 | 0.59 | 0.59 | 9.95 |
Q2 2020 | 160.00 | 0.71 | 0.74 | 10.21 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2010 | 160.00 | 0.50 | 0.50 | 2.78 |
2011 | 160.00 | 0.56 | 0.56 | 2.96 |
2012 | 160.00 | 0.59 | 0.59 | 3.55 |
2013 | 160.00 | 0.70 | 0.70 | 3.66 |
2014 | 160.00 | 0.81 | 0.81 | 8.25 |
2015 | 160.00 | 0.88 | 0.82 | 8.66 |
2016 | 160.00 | 0.46 | 0.46 | 8.56 |
2017 | 160.00 | 0.67 | 0.67 | 8.67 |
2018 | 160.00 | 0.56 | 0.56 | 9.24 |
2019 | 160.00 | 0.58 | 0.58 | 9.79 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | 51.42 | 51.42 | 5.14 |
Q4 2014 | 48.92 | 48.92 | 4.78 |
Q1 2015 | 51.53 | 55.54 | 5.14 |
Q2 2015 | 54.13 | 58.30 | 5.61 |
Q3 2015 | 44.33 | 47.69 | 4.57 |
Q4 2015 | 41.63 | 44.73 | 4.24 |
Q1 2016 | 36.41 | 36.41 | 3.14 |
Q2 2016 | 45.86 | 45.86 | 3.60 |
Q3 2016 | 36.32 | 36.32 | 2.62 |
Q4 2016 | 68.31 | 68.31 | 3.64 |
Q1 2017 | 61.37 | 61.37 | 3.50 |
Q2 2017 | 58.51 | 58.51 | 3.49 |
Q3 2017 | 47.94 | 47.94 | 2.91 |
Q4 2017 | 41.25 | 41.25 | 3.21 |
Q1 2018 | 39.28 | 39.28 | 3.07 |
Q2 2018 | 37.68 | 37.68 | 2.76 |
Q3 2018 | 32.21 | 32.21 | 2.27 |
Q4 2018 | 33.55 | 33.55 | 2.04 |
Q1 2019 | 35.91 | 35.91 | 1.98 |
Q2 2019 | 30.97 | 30.97 | 1.69 |
Q3 2019 | 32.09 | 32.09 | 1.73 |
Q4 2019 | 27.16 | 27.16 | 1.61 |
Q1 2020 | 24.17 | 24.17 | 1.42 |
Q2 2020 | 23.40 | 22.41 | 1.62 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2010 | - | - | - |
2011 | - | - | - |
2012 | - | - | - |
2013 | - | - | - |
2014 | 48.92 | 48.92 | 4.78 |
2015 | 41.63 | 44.73 | 4.24 |
2016 | 68.34 | 68.34 | 3.64 |
2017 | 41.25 | 41.25 | 3.21 |
2018 | 33.55 | 33.55 | 2.04 |
2019 | 27.16 | 27.16 | 1.61 |
Q2 2020
2020
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|---|---|
Q1 2017 | 150.74 | 29.49 |
Q2 2017 | 147.45 | 29.26 |
Q3 2017 | 136.70 | 26.31 |
Q4 2017 | 155.95 | 32.73 |
Q1 2018 | 140.85 | 59.82 |
Q2 2018 | 143.64 | 71.39 |
Q3 2018 | 140.83 | 109.03 |
Q4 2018 | 154.81 | 73.23 |
Q1 2019 | 146.91 | 82.77 |
Q2 2019 | 151.05 | 102.78 |
Q3 2019 | 149.00 | 71.00 |
Q4 2019 | 177.92 | 92.62 |
Q1 2020 | 152.48 | 54.21 |
Q2 2020 | 192.83 | 51.46 |
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|---|---|
2010 | 224.05 | 77.50 |
2011 | 244.33 | 86.33 |
2012 | 274.90 | 103.78 |
2013 | 317.00 | 117.11 |
2014 | 360.30 | 121.61 |
2015 | 451.60 | 109.71 |
2016 | 552.40 | 89.11 |
2017 | 590.84 | 117.78 |
2018 | 580.13 | 313.47 |
2019 | 624.88 | 349.18 |
Item | Q2 2020 (e) | Q2 2020 (a) | Change |
---|---|---|---|
Average | 21.98 | 39.10 | 77.94 % |
Item | Q2 2020 (e) | Q2 2020 (a) | Change |
---|---|---|---|
OSOOL AND BAKHEET | 39.10 | 39.10 | 0.0 % |
AlJazira Capital | 16.40 | 39.10 | 138.4 % |
SNB Capital | 16.40 | 39.10 | 138.4 % |
Al Rajhi Capital | 16.00 | 39.10 | 144.4 % |
Current | |
Market Cap (M Riyal) | 6,144.00 |
Enterprise Value (EV) (M) | 5,905.92 |
Shares Outstanding ((M)) | 160.00 |
EPS ( Riyal) (TTM) | 2.04 |
Book Value (BV) ( Riyal) | 12.11 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 23.23 |
P/E (TTM) | 18.83 |
Price/book | 3.17 |
Return on Average Assets (%) (TTM) | 12.5 |
Return on Average Equity (%) (TTM) | 17.3 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}